Engineered Wnt ligands enable blood-brain barrier repair in neurological disorders

Author:

Martin Maud1ORCID,Vermeiren Simon1,Bostaille Naguissa1ORCID,Eubelen Marie1ORCID,Spitzer Daniel2,Vermeersch Marjorie3,Profaci Caterina P.4ORCID,Pozuelo Elisa5,Toussay Xavier6ORCID,Raman-Nair Joanna6,Tebabi Patricia1,America Michelle1,De Groote Aurélie5,Sanderson Leslie E.1ORCID,Cabochette Pauline1ORCID,Germano Raoul F. V.1ORCID,Torres David7ORCID,Boutry Sébastien3ORCID,de Kerchove d’Exaerde Alban5ORCID,Bellefroid Eric J.8ORCID,Phoenix Timothy N.9ORCID,Devraj Kavi2ORCID,Lacoste Baptiste6ORCID,Daneman Richard4ORCID,Liebner Stefan2ORCID,Vanhollebeke Benoit110ORCID

Affiliation:

1. Laboratory of Neurovascular Signaling, Department of Molecular Biology, ULB Neuroscience Institute, Université libre de Bruxelles, Gosselies B-6041, Belgium.

2. Institute of Neurology (Edinger Institute), University Hospital, Goethe University Frankfurt, Frankfurt am Main, Germany.

3. Center for Microscopy and Molecular Imaging, Université libre de Bruxelles, Université de Mons, Gosselies B-6041, Belgium.

4. Departments of Pharmacology and Neurosciences, University of California, San Diego, La Jolla, CA, USA.

5. Laboratory of Neurophysiology, ULB Neuroscience Institute, Université libre de Bruxelles, Brussels B-1070, Belgium.

6. Ottawa Hospital Research Institute, Neuroscience Program, Department of Cellular and Molecular Medicine, University of Ottawa Brain and Mind Research Institute, Faculty of Medicine, Ottawa, Ontario, Canada.

7. Institut d’Immunologie Médicale, Université libre de Bruxelles, Gosselies, Belgium.

8. Laboratory of Developmental Genetics, ULB Neuroscience Institute, Université libre de Bruxelles, Gosselies B-6041, Belgium.

9. Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH, USA.

10. Walloon Excellence in Life Sciences and Biotechnology (WELBIO), Wavre, Belgium.

Abstract

The blood-brain barrier (BBB) protects the central nervous system (CNS) from harmful blood-borne factors. Although BBB dysfunction is a hallmark of several neurological disorders, therapies to restore BBB function are lacking. An attractive strategy is to repurpose developmental BBB regulators, such as Wnt7a, into BBB-protective agents. However, safe therapeutic use of Wnt ligands is complicated by their pleiotropic Frizzled signaling activities. Taking advantage of the Wnt7a/b-specific Gpr124/Reck co-receptor complex, we genetically engineered Wnt7a ligands into BBB-specific Wnt activators. In a “hit-and-run” adeno-associated virus–assisted CNS gene delivery setting, these new Gpr124/Reck-specific agonists protected BBB function, thereby mitigating glioblastoma expansion and ischemic stroke infarction. This work reveals that the signaling specificity of Wnt ligands is adjustable and defines a modality to treat CNS disorders by normalizing the BBB.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3